Two Sigma Advisers’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-469,300
Closed -$96.4M 353
2025
Q4
$96.4M Buy
469,300
+453,700
+2,908% +$85.4M 0.19% 120
2025
Q3
$2.45M Sell
15,600
-347,700
-96% -$53.7M ﹤0.01% 1043
2025
Q2
$61M Sell
363,300
-162,800
-31% -$24.2M 0.13% 161
2025
Q1
$72.5M Sell
526,100
-157,700
-23% -$20.1M 0.16% 133
2024
Q4
$80.9M Sell
683,800
-385,662
-36% -$45M 0.19% 106
2024
Q3
$118M Buy
1,069,462
+346,362
+48% +$36.2M 0.28% 81
2024
Q2
$71.1M Buy
723,100
+276,900
+62% +$28.2M 0.16% 131
2024
Q1
$49.9M Buy
446,200
+113,600
+34% +$12.3M 0.12% 185
2023
Q4
$33.5M Buy
332,600
+252,500
+315% +$25.1M 0.08% 244
2023
Q3
$6.95M Sell
80,100
-5,100
-6% -$461K 0.02% 594
2023
Q2
$8.06M Sell
85,200
-344,800
-80% -$29.1M 0.02% 572
2023
Q1
$32.5M Sell
430,000
-381,100
-47% -$28.8M 0.08% 228
2022
Q4
$62.3M Buy
811,100
+337,500
+71% +$25.6M 0.17% 126
2022
Q3
$31.6M Buy
473,600
+325,600
+220% +$20.6M 0.09% 226
2022
Q2
$7.74M Buy
148,000
+40,600
+38% +$2.31M 0.02% 590
2022
Q1
$6.09M Sell
107,400
-414,600
-79% -$22.2M 0.02% 715
2021
Q4
$26.9M Buy
522,000
+290,300
+125% +$14.2M 0.07% 251
2021
Q3
$11.5M Buy
231,700
+5,700
+3% +$309K 0.03% 475
2021
Q2
$12.9M Sell
226,000
-59,500
-21% -$3.48M 0.03% 473
2021
Q1
$17.3M Sell
285,500
-318,800
-53% -$17.6M 0.05% 395
2020
Q4
$32.4M Sell
604,300
-107,200
-15% -$5.56M 0.09% 242
2020
Q3
$33.4M Buy
711,500
+39,800
+6% +$2.04M 0.1% 207
2020
Q2
$35.1M Buy
671,700
+24,500
+4% +$1.26M 0.1% 211
2020
Q1
$31M Sell
647,200
-188,146
-23% -$9.77M 0.12% 199
2019
Q4
$42.3M Sell
835,346
-125,293
-13% -$6.47M 0.1% 230
2019
Q3
$45.3M Sell
960,639
-537,600
-36% -$24.5M 0.11% 216
2019
Q2
$70.6M Buy
1,498,239
+184,800
+14% +$8.52M 0.18% 146
2019
Q1
$63.2M Sell
1,313,439
-377,800
-22% -$18.9M 0.16% 169
2018
Q4
$75.4M Sell
1,691,239
-455,000
-21% -$23.7M 0.21% 126
2018
Q3
$116M Buy
2,146,239
+1,713,400
+396% +$87.7M 0.28% 92
2018
Q2
$21.1M Buy
432,839
+50,700
+13% +$2.87M 0.06% 381
2018
Q1
$24M Sell
382,139
-549,734
-59% -$37.7M 0.06% 360
2017
Q4
$57.1M Buy
931,873
+360,520
+63% +$22.3M 0.15% 172
2017
Q3
$38.2M Buy
571,353
+43,618
+8% +$3.08M 0.11% 231
2017
Q2
$41.1M Sell
527,735
-113,404
-18% -$8.56M 0.14% 188
2017
Q1
$52.3M Sell
641,139
-1,016,824
-61% -$80M 0.17% 144
2016
Q4
$119M Buy
1,657,963
+1,422,001
+603% +$103M 0.46% 48
2016
Q3
$18.3M Buy
235,962
+215,807
+1,071% +$17.4M 0.08% 290
2016
Q2
$1.57M Buy
+20,155
New +$1.61M 0.01% 961
2016
Q1
Sell
-4,697
Closed -$419K 2035
2015
Q4
$419K Sell
4,697
-32,498
-87% -$2.76M ﹤0.01% 1394
2015
Q3
$2.86M Sell
37,195
-74,932
-67% -$6.26M 0.02% 632
2015
Q2
$9.38M Buy
+112,127
New +$9.9M 0.07% 317
2015
Q1
Sell
-21,351
Closed -$1.72M 1942
2014
Q4
$1.72M Buy
21,351
+9,896
+86% +$781K 0.01% 896
2014
Q3
$858K Sell
11,455
-59,096
-84% -$4.3M 0.01% 1224
2014
Q2
$4.84M Buy
70,551
+60,300
+588% +$4.11M 0.04% 489
2014
Q1
$718K Sell
10,251
-14,300
-58% -$994K 0.01% 1342
2013
Q4
$1.64M Buy
24,551
+10,796
+78% +$660K 0.02% 851
2013
Q3
$717K Buy
+13,755
New +$699K 0.01% 1159

Other funds holding CAH

Two Sigma Advisers's CAH Position: Q1 2026 in Review

Two Sigma Advisers sold out of Cardinal Health (CAH) in Q1 2026, closing a stake of 469,300 shares — an estimated $96.4M sold.

Two Sigma Advisers first reported a position in CAH in Q3 2013 and held it in 48 quarters. The position peaked at $119M in Q4 2016. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Two Sigma Advisers reported no remaining Cardinal Health position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 469,300 Cardinal Health shares in Q1 2026, an estimated $96.4M.
  • Two Sigma Advisers first reported a position in Cardinal Health in Q3 2013 and held it in 48 quarters.
  • Two Sigma Advisers's Cardinal Health position peaked at $119M in Q4 2016.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.